Company / Current Liabilities per Share
aTYR PHARMA INC Current Liabilities per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$0.18
FY2025
5-year range
$0.18 / $0.56
FY2021-FY2025
Trend
-23.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $0.56 to $0.18 over the past 2 years.
Based on SEC 10-K filings.
0.18 in FY2025 with a 5-year CAGR of -34.6%.
Improved from $0.56 to $0.18 over the past 2 years.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- -28.8%
- 5-Year CAGR
- -34.6%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, current liabilities per share decreased 23.8% year-over-year.
- Peak current liabilities per share was recorded in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -6.50 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.18 | -23.8% |
| FY2024 | $0.24 | -57.5% |
| FY2023 | $0.56 | +11.6% |
| FY2022 | $0.50 | -8.6% |
| FY2021 | $0.55 | -63.8% |
| FY2020 | $1.51 | -74.5% |
| FY2019 | $5.91 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026